Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for the Simponi (golimumab) biosimilar, BAT2506 in the US. Bio-Thera will develop ...

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

Acamprosate is used to treat alcohol dependence along with other rehabilitation therapy such as counseling and social support in people who have the intention of avoiding alcohol consumption.

Intas Pharma becomes most valuable privately held pharma company A PE deal values Intas at Rs 23,000 crore or USD 3.5 billion, making it the most valued pharma privately held company in India.

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest ...

Other unlisted companies that have been placed in the top 10 in the report in terms of valuation are Megha Engineering & ...

Johnson & Johnson (NYSE:JNJ) is reportedly suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's blockbuster drug Stelara, also known as ustekinumab. In its suit, ...

On February 10, 2025, Bio-Thera Solutions, Ltd. announced that they entered into an exclusive licensing agreement with Intas Pharmaceuticals Ltd. to commercialize BAT2506 (golimumab), Bio-Thera ...

Among them, the cardiac, gastrointestinal, and antidiabetic therapies saw high value growth of 9.5 per cent, 9.6 per cent, ...

Telangana: Natco Pharma has appointed Bhimrao Dattu Jadhav as Senior Vice President - Operations (Formulations) for Pharma ...

Learn about Intas Pharmaceuticals in Dehradun, Uttarakhand.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...